Omada Health, Inc.
OMDA Healthcare Health Information Services
Omada Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $260.2 million, up 53.2% from fiscal 2024. In the quarter to June 2026, revenue grew 43.1%, EPS grew 137.5% and free cash flow grew 45.7%, each against the same quarter a year earlier.
Follow OMDA
Omada Health, Inc. (OMDA) P/E ratio
As of 16 October 2026, Omada Health, Inc. (OMDA) trades at a P/E ratio of 252×. Over the past ten years it has ranged from 0.0× (June 2026) to 357× (August 2026); the current reading is higher than 77% of that period. That is above the Health Information Services industry median of 39.8× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 314× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 4 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TDOC Teladoc Health, Inc. compare | n/m |
| SDGR Schrodinger, Inc. compare | n/m |
| MDRX Veradigm Inc. compare | n/m |
| CERT Certara, Inc. compare | n/m |
| OMCL Omnicell, Inc. compare | 41.6× |
| HSTM HealthStream, Inc. compare | 46.0× |
| GDRX GoodRx Holdings, Inc. compare | 62.7× |
| PHR Phreesia, Inc. compare | 64.4× |
| OMDA Omada Health, Inc. | 252× |
| Health Information Services industry median | 39.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)